TY - JOUR AU - Debinski, Waldemar PY - 2017 TI - When better still might not be good enough JF - Translational Cancer Research; Vol 6, Supplement 7 (October 24, 2017): Translational Cancer Research Y2 - 2017 KW - N2 - Immunotherapy has brought, arguably, the biggest advances in cancer treatment in recent years. Cancer immunotherapy can be divided into active and passive approaches. For example, vaccines are an active immunotherapy where the patient’s own immune system is mobilized to fight malignancy. On the other hand, passive immunotherapy relies on administering the effector arms of the immune system like antibodies or T cells. UR - https://tcr.amegroups.org/article/view/16322